SCHEMBL7629261

SCHEMBL7629261

CC(C)C(Cl)C[SiH](C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6883242 0.67
SCHEMBL447933 0.65
SCHEMBL5613441 0.65
SCHEMBL20955836 0.62
SCHEMBL11204404 0.62
SCHEMBL7863854 0.62
SCHEMBL22597647 0.60
SCHEMBL10423301 0.60
SCHEMBL21985218 0.60
SCHEMBL3658527 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4614616-A Process for preparing 3β7β-dihydroxy-Δ5 -steroids SCHERING AKTIENGESELLSCHAFT (DE) 1986-09-30 US claimed
EP-0051143-B1 PROCESS FOR THE PREPARATION OF 3-BETA, 7-BETA-DIHYDROXY-DELTA-5 STEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 1984-07-04 EP claimed
US-4416985-A Process for preparing 3β,7β-dihydroxy-Δ5 -steroids SCHERING, AKTIENGESELLSCHAFT (DE) 1983-11-22 US claimed
EP-0051143-A1 Process for the preparation of 3-beta, 7-beta-dihydroxy-delta-5 steroids SCHERING AKTIENGESELLSCHAFT (DE) 1982-05-12 EP claimed
EP-0741716-B1 DELTA 12,13 -ISO-TAXOL ANALOGS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM UPJOHN CO (US) 2002-07-24 EP disclosed
US-5821363-A Antineoplastic use and pharmaceutical compositions containing them PHARMACIA & UPJOHN COMPANY (US) 1998-10-13 US disclosed
EP-0741716-A1 DELTA 12,13 -ISO-TAXOL ANALOGS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PHARMACIA &amp; UPJOHN COMPANY (US) 1996-11-13 EP disclosed
WO-1995020582-A1 Δ12,13-ISO-TAXOL ANALOGS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PHARMACIA & UPJOHN COMPANY (US) 1995-08-03 WO disclosed
EP-0163596-B1 ESTRIOL ESTERS SCHERING AKTIENGESELLSCHAFT (DE) 1990-08-16 EP disclosed
EP-0273242-A2 2-Pyri(mi)dylthio-aryl ether BAYER AG (DE) 1988-07-06 EP disclosed
US-4681875-A CONTRACEPTIVES, GYNECOLOGY SCHERING AKTIENGESELLSCHAFT (DE) 1987-07-21 US disclosed
US-4614616-A Process for preparing 3β7β-dihydroxy-Δ5 -steroids SCHERING AKTIENGESELLSCHAFT (DE) 1986-09-30 US disclosed
US-4614616-A Process for preparing 3β7β-dihydroxy-Δ5 -steroids SCHERING AKTIENGESELLSCHAFT (DE) 1986-09-30 US disclosed
EP-0163596-A1 Estriol esters SCHERING AKTIENGESELLSCHAFT (DE) 1985-12-04 EP disclosed
EP-0051143-B1 PROCESS FOR THE PREPARATION OF 3-BETA, 7-BETA-DIHYDROXY-DELTA-5 STEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 1984-07-04 EP disclosed
US-4416985-A Process for preparing 3β,7β-dihydroxy-Δ5 -steroids SCHERING, AKTIENGESELLSCHAFT (DE) 1983-11-22 US disclosed
US-4416985-A Process for preparing 3β,7β-dihydroxy-Δ5 -steroids SCHERING, AKTIENGESELLSCHAFT (DE) 1983-11-22 US disclosed
EP-0051143-A1 Process for the preparation of 3-beta, 7-beta-dihydroxy-delta-5 steroids SCHERING AKTIENGESELLSCHAFT (DE) 1982-05-12 EP disclosed
EP-0051143-A1 Process for the preparation of 3-beta, 7-beta-dihydroxy-delta-5 steroids SCHERING AKTIENGESELLSCHAFT (DE) 1982-05-12 EP disclosed